BioCorRx (BICX) EBIT Growth (3y) (2013 - 2026)
BioCorRx (BICX) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | -27.36% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 35.45% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 44.08% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 12.63% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 16.30% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 22.64% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 30.20% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 8.67% |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 11.91% |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.27% |
| Dec 31, 2025 | -61.68% |
| Sep 30, 2025 | 29.57% |
| Jun 30, 2025 | -1.35% |
| Mar 31, 2025 | 5.87% |
| Dec 31, 2024 | 5.50% |
| Sep 30, 2024 | -0.51% |
| Jun 30, 2024 | -12.44% |
| Mar 31, 2024 | 15.03% |
| Dec 31, 2023 | 22.50% |
| Sep 30, 2023 | 22.33% |
| Jun 30, 2023 | 23.97% |
| Mar 31, 2023 | 11.38% |
| Dec 31, 2022 | 9.42% |
| Sep 30, 2022 | -5.13% |
| Jun 30, 2022 | 5.31% |
| Mar 31, 2022 | 14.04% |
| Dec 31, 2021 | 30.10% |
| Sep 30, 2021 | -5.27% |
| Jun 30, 2021 | -9.12% |